# ClinicalTrials.gov record NCT04554940

> PeptideScanner retained ClinicalTrials.gov record NCT04554940 at 2026-07-30T16:22:22.328Z. Its registry update date was 2026-03-13, and PeptideScanner's reviewed identity mapping was vosoritide.

- Evidence object: `story:clinicaltrials-gov-nct04554940-vosoritide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-03-13
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-08
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct04554940-vosoritide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct04554940-vosoritide-v1.json
- Content SHA-256: `6d65137570e43f9b6c65a1972cc18b4e2c020e5dd2eee0b34bd810b051e386e6`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT04554940 ([`ctg-observation-nct04554940-2026-03-13-572bf42dd5bf`](#source-ctg-observation-nct04554940-2026-03-13-572bf42dd5bf))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT04554940 at 2026-07-30T16:22:22.328Z. Its registry update date was 2026-03-13, and PeptideScanner's reviewed identity mapping was vosoritide. ([`ctg-observation-nct04554940-2026-03-13-572bf42dd5bf`](#source-ctg-observation-nct04554940-2026-03-13-572bf42dd5bf))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT04554940 at 2026-07-30T16:22:22.328Z. Its registry update date was 2026-03-13, and PeptideScanner's reviewed identity mapping was vosoritide. ([`ctg-observation-nct04554940-2026-03-13-572bf42dd5bf`](#source-ctg-observation-nct04554940-2026-03-13-572bf42dd5bf))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct04554940-2026-03-13-572bf42dd5bf`](#source-ctg-observation-nct04554940-2026-03-13-572bf42dd5bf))

## Sources

<a id="source-ctg-observation-nct04554940-2026-03-13-572bf42dd5bf"></a>
- **ClinicalTrials.gov record NCT04554940 · retained source version 2026-03-13:572bf42dd5bf732d4533515d7d4c4855d352cda00f531c83b01a83c30085087a** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT04554940) (`ctg-observation-nct04554940-2026-03-13-572bf42dd5bf`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT04554940." Version 1, published 2026-08-08. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct04554940-vosoritide-v1.json SHA-256: 6d65137570e43f9b6c65a1972cc18b4e2c020e5dd2eee0b34bd810b051e386e6.